Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1967-7-10
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0543-3002
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
545-54
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:6013064-Abnormalities, Drug-Induced,
pubmed-meshheading:6013064-Animals,
pubmed-meshheading:6013064-Female,
pubmed-meshheading:6013064-Growth,
pubmed-meshheading:6013064-Hydroxamic Acids,
pubmed-meshheading:6013064-Male,
pubmed-meshheading:6013064-Mice,
pubmed-meshheading:6013064-Phenylacetates,
pubmed-meshheading:6013064-Rats
|
pubmed:year |
1966
|
pubmed:articleTitle |
[Pharmacological study of p-butoxyphenylacethydroxamic acid (CP 1044 J3). II. Toxicological research].
|
pubmed:publicationType |
Journal Article
|